This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Sirui Li, PhD
Research Associate, Laboratory of Dr. Jenny Ting at University of North Carolina at Chapel Hill


I am a research associate working with Dr. Jenny P-Y Ting at Lineberger Comprehensive Cancer Center of University of North Carolina at Chapel Hill. I am focusing on identifying novel immunotherapies for treating advanced tumor based on the integrated molecular mechanisms. During my PhD training in University of Chinese Academy of Sciences, I investigated the chronic hepatitis' malignant transformation process and relapsed breast cancer's immunotherapy. I am interested in the immunotherapy of advanced tumor including solid tumor, relapsed tumor and metastatic tumor, as well as the mechanism of inflammation associated disease-relevant issues including fibrosis and colitis. My research will reveal molecular navigation chart of the immune system that are responsible for disease disorders, providing correspondent cell type targets for therapeutic interventions.

Agenda Sessions

  • The Perspective of STING Agonists and IL-35 Blockade in Solid Tumor Therapy